High Performance Dioxin/Furan Immunoassay Kit Insert (IN-DF1)
Last Revised: 12/4/98

Contents of This Insert

A.

Intended Use

B.

Background Information

C.

Test Principles

D.

Performance Characteristics

E.

Precautions
F. Materials Provided
G. Materials Supplied by the User
H. Suggestions for Pipettor Use
I. Preparation of PCDD/F Sample Extracts for EIA by Solvent Exchange
J. EIA Analysis of Standards and Prepared Samples
K. Interpretation of the Results
L. Limitations of the Procedure
M. Storage
N. Quality Assurance
O. References
P. General Limited Warranty

A.

Intended Use
The CAPE Technologies High Performance Dioxin/Furan Immunoassay Kit is an Enzyme Immunoassay (EIA) for analysis of Polychlorinated DibenzoDioxins and Polychlorinated DibenzoFurans (PCDD/Fs) in prepared sample extracts. Extracts of fly ash, soil, stack gas, tissue, sediment, water, or other samples which have been prepared by conventional extraction methods can be exchanged to methanol for EIA analysis.

Samples can also be prepared by immunoassay specific methods for analysis by EIA. Please read this kit insert and other related CAPE Technologies literature carefully to gain maximum understanding of the capabilities and limitations of the test.

Note: Samples analyzed by EIA must contain either immunoassay compatible internal standards or no internal standards. Please consult Technical Note TN-001 for further discussion of internal standards. Refer to other Technical Notes and Application Notes available from CAPE Technologies for discussion of technical issues and individual applications.

B.

Background Information
  PCDD/Fs are a family of compounds with the same general structure. There are 75 dibenzodioxin congeners and 135 dibenzofuran congeners, containing from 1 to 8 chlorine atoms on the dibenzodioxin or dibenzofuran nucleus. Only 7 of the 75 PCDD congeners and 10 of the 135 PCDF congeners contain the 2,3,7,8 chlorination pattern thought to be required for dioxin-like toxicity. Only these 17 of the 210 total PCDD/F congeners contribute to the Toxic Equivalency (TEQ) of a sample, which is generally the critical analytical target. Based on a variety of toxicity tests, these 17 congeners have been assigned Toxic Equivalency Factors (TEFs) of 1.0 to 0.001 relative to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

The PCDD/F congener composition of samples can be highly variable. Because PCDD/Fs are formed unintentionally by a variety of chemical and combustion processes, samples usually contain a mixture of many different congeners. Samples from different sources often have very different mixtures of congeners which are consistent within the source. In most samples, the majority of the PCDD/F mass present does not contribute significantly to the total sample TEQ. Also, in most samples, only a few PCDD/F congeners are responsible for the majority of the TEQ. This immunoassay is designed to measure sample TEQ by responding to the toxic PCDD/F congeners in correlation with their TEFs. The variability of congener composition noted above can cause practical difficulties in using the immunoassay to produce quantitative results. Consequently, this kit is designed for screening analysis of PCDD/F samples at preselected or user determined levels. Please consult CAPE Technologies Technical Note TN-004 for further discussion of quantitative use of the kit.

C.

Test Principles
  PCDD/Fs are typically extracted with organic solvents which are incompatible with the EIA. Before introduction of the sample into the EIA a solvent exchange is required. PCDD/Fs have very low volatility and are retained within a thin layer of detergent after evaporation of the original solvent. Methanol is added to redissolve the PCDD/Fs and this solution is added directly to the EIA tubes. It should be noted that the literature value for solubility of 2,3,7,8-TCDD in methanol is 10 ppm, which is 1000 times higher than the concentration of the highest standard recommended for this kit.

During the first EIA incubation, PCDD/Fs are specifically bound by the anti-dioxin antibodies, which have been immobilized on the EIA tube surface. After washing away the unbound material, the bound PCDD/Fs remain and a competitor-HorseRadish Peroxidase (HRP) conjugate is added. Bound PCDD/Fs occupy the dioxin binding sites of the antibodies in proportion to the PCDD/F content of the sample and prevent binding of the competitor-HRP conjugate. After a short incubation, unbound conjugate is removed and the test tubes are washed thoroughly. The amount of conjugate bound by the anti-dioxin antibody is inversely related to the amount of PCDD/Fs originally present in the sample.

Finally, a solution of chromogenic HRP substrate and hydrogen peroxide is added to the test tubes. Color development is directly proportional to enzyme concentration and inversely related to the PCDD/F concentration in the original sample. The test tubes are analyzed using a tube reader or spectrophotometer to measure the optical density (OD) at 450 nm. The OD values of unknown samples are compared to the OD values of standards to determine the level of PCDD/Fs in the samples.

D.

Performance Characteristics
  Sensitivity and Reproducibility
Standard curve data developed by CAPE Technologies for the High Performance Dioxin/Furan Immunoassay Kit are given in Table 1. Response values are expressed as a percentage of the negative control, which is 200 ppb Triton X-100 in methanol. The detection limit of the kit is approximately 4 pg 2,3,7,8-TCDD per EIA tube. Results for samples which are compared to the standards shown in Table 1 must be related to the original sample concentration by back calculation using the proper dilution and volume factors. Matrix detection limits will vary according to matrix, sample size, and dilution factor. Consult the appropriate CAPE Technologies Application Note for further information. The data in Table 1 can be used to determine if kit performance is acceptable. If your results for the standards in Table 1 are not consistently within the percent of negative control ranges given, contact CAPE Technologies for assistance.

Table 1: Sensitivity and Reproducibility of the EIA Standard Curve. Data are accumulated responses for 2,3,7,8-TCDD standards in methanol/Triton over ten months. No sample matrix was present. A total of 41 tests were run in four different labs. The detection limit, which is approximated by the I85 or the concentration giving 85% of the negative control OD, was 3.9±1.4 pg/tube (mean±SD). The midpoint of the curve, defined as the I50 or the concentration giving 50% of the negative control OD, was 21.9±7.4 pg/tube (mean±SD).

pg/EIA tube
(ppb in Standard)

3.2
(0.32)

10
(1.0)

32
(3.2)

100
(10)

mean percent
of negative control
(%NC)

87

66

41

29

Standard Deviation (SD) 6 7 7 6
Range of
Mean ±2SD
74-99 51-80 27-55 17-40
  Specificity
The anti-dioxin antibody in this kit binds to different PCDD/F congeners with different affinities. The specificity of the test is predominantly for PCDD/Fs which contain 3 to 6 chlorines, with a strong preference for the 2,3,7,8 chlorinated congeners. Test specificity roughly parallels the TEF values of the individual PCDD/F congeners. Crossreactivity data given in the following table are reactivities relative to 2,3,7,8-TCDD.

Table 2: Specificity of the EIA. Response curves were prepared for each congener as noted. The percent crossreactivity = (((congener I50) ÷ (2,3,7,8-TCDD I50)) x 100). Values are typically based on 2 to 4 independent curves, each containing at least 4 concentrations.
Toxic Dioxin Congeners Percent
Crossreactivity

2,3,7,8-TCDD

100

1,2,3,7,8-PeCDD

105

1,2,3,4,7,8-HxCDD

1.6

1,2,3,6,7,8-HxCDD

7.9

1,2,3,7,8,9-HxCDD

39

1,2,3,4,6,7,8-HpCDD

0.7

OCDD

<0.001

Toxic Furan Congeners Percent
Crossreactivity

2,3,7,8-TCDF

20

1,2,3,7,8-PeCDF

4.6

2,3,4,7,8-PeCDF

17

1,2,3,4,7,8-HxCDF

0.4

1,2,3,6,7,8-HxCDF

1.0

1,2,3,7,8,9-HxCDF

3.3

2,3,4,6,7,8-HxCDF

4.9

1,2,3,4,6,7,8-HpCDF

0.02

1,2,3,4,7,8,9-HpCDF

0.9

OCDF

<0.001

Other PCDD/F Congeners Percent
Crossreactivity

2,3-dichlorodibenzo-p-dioxin

0.13

2,7-dichlorodibenzo-p-dioxin

0.003

2,3-dichlorodibenzofuran

0.02

2,7-dichlorodibenzofuran

<0.002

2,3,7-trichlorodibenzo-p-dioxin

24

2,3,8-trichlorodibenzofuran

0.26

1,2,3,4-TCDD

<0.001

1,2,3,4-TCDF

<0.001

1,3,6,8-TCDD

0.05

1,3,6,8-TCDF

0.007

PolyChlorinated Biphenyls Percent
Crossreactivity

3,3',4,4' (PCB 77)

0.4

3,3',4,4',5 (PCB 126)

0.5

2,2',4,4',5 (PCB 153)

<0.1

3,3',4,4',5,5' (PCB 169)

<0.1

Aroclor 1254

<0.1


 
 
../logo.jpg%20(3883%20bytes) Phone - (207) 741-2995
Fax - (207) 741-2996
Email - cape-tech@ceemaine.org
Copyright ©1998 CAPE Technologies L.L.C. All rights reserved.